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among groups were estimated by χ2 test, bone metastasis-free survival 
was analyzed by Kaplan-Meier method. The prognostic impact of 
clinicopathologic parameters and biomarker expression was evaluated 
by Cox propotional hazards model.
Results: BSP expression was associated with BM(P=0.027), OPN 
expression could not reach statistical signiﬁcance(P=0.495). Survival 
analysis demonstrated that strong expression of BSP(P=0.036), N 
stage(P=0.000) and overall stage(P=0.001) were associated with time 
interval to BM. Multivariate analysis showed BSP expression(RR=1.7
79,P=0.012) and overall stage(RR=1.620,P=0.005) were independent 
prognostic factors for BM. 
Conclusions: BSP protein expression in the primary resected NSCLC 
is strongly associated with BM and could be used to identify high-risk 
patients, and further improve treatment of NSCLC. Correlation of OPN 
protein expression and bone metastasis need further investigation.
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Background: Lung cancer remains to be the leading cause of mortal-
ity for cancer deaths despite the availability of various chemo- and 
radiotherapeutic regimens. One of the limitations is due to resistance 
of cancers cells to apoptotic stimuli of various anti-neoplastic agents. 
Autophagic cell death has recently been shown to be increased in the 
irradiated apoptosis-incompetent cells.
Method: We tested whether inhibition of apoptosis and induction of 
autophagy can be utilized as an adjunctive to the radiation therapy, 
using cell culture and xenograft models of lung cancer. In order to test 
this hypothesis, we asked whether inhibitor of Caspase-3, Z-DEVD, 
and inducer of autophagy, RAD001, can enhance the cytotoxic effects 
of irradiation in human lung cancer cells, H460. 
Result: We found that combination of Z-DVED and RAD001 
markedly enhanced radiosensitization of H460 cells than individual 
treatment alone both in vitro as well as xenograft murine model. The 
enhanced radiosensitization was associated with upregulation of au-
tophagosome formatiom. Furthermore, when we addressed the speciﬁc 
cellular behavior associated with combination treatment, we observed 
defects in angiogenesis, inhibition of proliferation, as well as reduction 
in apoptosis. 
Conclusion: We demonstrate that radiation therapy, combined with 
inhibition of Caspase-3 and induction of autophagy, may be a novel 
therapeutic option for lung cancer patients. 
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The aim of this work was to study cytogenetic damages in vivo induced 
by single therapeutic irradiation in population of peripheral blood 
lymphocytes (PBL) of squamous cell lung cancer (SCLC) patients and 
to estimate the possibilities of using these date for prediction of tumour 
radiosensitivity. It becomes especially urgent in connection with accel-
eration of growth in the number of oncological cases in areas suffering 
from the Chernobyl accident. 
The estimation of lymphocytes with micronuclei and apoptosis in PBL 
of the patients was carried out before and after single therapeutic irra-
diation (4 Gy). The criterion of patient somatic cell radiosensitivity was 
the response of tumour tissue to radiotherapy. Depending on treatment 
result all patients were divided into radiosensitive and radioresistant 
groups. 
It was revealed that the levels of spontaneous mutational (0,32±0,10%) 
and cell-lethal (6,33±0,45%) processes in PBL in vivo in SCLC pa-
tients with clinically radiosensitive tumours were 1,5-2 fold as high as 
in the control (0,14±0,08% - cells with micronuclei; 4,13±0.67% - cells 
with apoptosis), and in patients with clinically radioresistant tumours 
didn’t differ from those in people without oncopathology. 
After single therapeutic irradiation signiﬁcant increase (1,5-2 fold) 
in the lymphocyte level with micronuclei and degenerative disorders 
was observed in patients with high tumour tissue radiosensitivity in 
comparison with the spontaneous level in the same patients, with the 
absence of essential changes being noted between the levels in patients 
with radioresistant tumour tissue. 
Thus, studying cytogenetic parameters of the mutational process and 
the cell-lethal effect in vivo in PBL of patients suffering from SCLC 
has established additional criteria for estimating and predicting radio-
sensitivity of somatic cells in SCLC patients for increasing radiothera-
phy efﬁciency.
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Background: Non-small cell lung cancer (NSCLC) cells are com-
monly progressed to radiation-resistant state, making it difﬁcult to treat 
by conventional radiotherapy. The aim of this study is to establish the 
